tiprankstipranks
Trending News
More News >
NanoViricides (NNVC)
:NNVC
US Market

NanoViricides (NNVC) Financial Statements

Compare
602 Followers

NanoViricides Financial Overview

NanoViricides's market cap is currently $25.45M. The company's EPS TTM is $-0.135; its P/E ratio is -2.32; NanoViricides is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -747.53K$ 0.00$ 0.00
Operating Income$ -9.59M$ -8.52M$ -8.94M$ -8.11M$ -8.74M
EBITDA$ -8.72M$ -7.49M$ -7.84M$ -7.38M$ -8.04M
Net Income$ -9.47M$ -8.29M$ -8.59M$ -8.11M$ -8.82M
Balance Sheet
Cash & Short-Term Investments$ 1.56M$ 4.80M$ 8.15M$ 14.07M$ 20.52M
Total Assets$ 8.82M$ 12.82M$ 16.90M$ 23.49M$ 30.26M
Total Debt$ 0.00$ 0.00$ 0.00$ 94.79K$ 95.31K
Net Debt$ -1.56M$ -4.80M$ -8.15M$ -13.97M$ -20.42M
Total Liabilities$ 1.31M$ 1.36M$ 2.03M$ 412.84K$ 351.15K
Stockholders' Equity$ 7.52M$ 11.46M$ 14.87M$ 23.08M$ 29.91M
Cash Flow
Free Cash Flow$ -8.54M$ -6.47M$ -5.82M$ -6.22M$ -8.45M
Operating Cash Flow$ -8.48M$ -6.32M$ -5.67M$ -5.89M$ -8.21M
Investing Cash Flow$ -56.96K$ -156.56K$ -151.71K$ -324.35K$ -238.76K
Financing Cash Flow$ 5.30M$ 3.12M$ -94.79K$ -234.72K$ 15.26M
Currency in USD

NanoViricides Earnings and Revenue History

NanoViricides Debt to Assets

NanoViricides Cash Flow

NanoViricides Forecast EPS vs Actual EPS